Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas.
about
Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosisPharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis.Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis: Randomized, Controlled, Multicenter Trial.
P2860
Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@en
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@nl
type
label
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@en
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@nl
prefLabel
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@en
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@nl
P2093
P2860
P356
P1476
Inhaled versus systemic antibi ...... stic fibrosis and Pseudomonas.
@en
P2093
Kathleen A Abode
Margaret W Leigh
Marianna M Henry
Paul W Stewart
Peter H Michelson
Sally S Ivins
Terry L Noah
William T Harris
P2860
P304
P356
10.1002/PPUL.21176
P577
2010-03-01T00:00:00Z